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The relative contribution of bacterial components to the induction of inflammation dur-
ing Streptococcus pneumoniae meningitis is unknown. Several strains of pneumococci
with differences in cell surface characteristics (capsule or cell wall) were compared for
the effect on the inflammatory response evoked during infection of the cerebrospinal
fluid (CSF) in vivo. The presence of bacterial capsular polysaccharide was not necessary
for bacterial growth in CSF in vivo but correlated with greater CSF bacterial density. CSF
inflammatory changes began to appear when the bacterial concentration exceeded 105
cfu/ml, regardless of the pneumococcal strain. CSF inflammatory changes could be in-
voked by cisternal instillation of 105-106 cell equivalents of whole, heat-killed unencapsu-
lated strains or their isolated cell walls but not by similar concentrations of heat-killed
encapsulated strains or isolated capsular polysaccharide. Hypoglycorrhachia was ob-
served only during inflammation caused by live bacteria. The inflammatory response
characteristic of naturally acquired pneumococcal meningitis can be reproduced by chal-
lenge with both encapsulated and unencapsulated bacteria. The bacterial cell wall ap-
pears to be the most potent pneumococcal surface component in inducing CSF inflam-
mation.
Many steps in the pathogenesis of pneumococcal
meningitis remain unclear. This is particularly true
in regard to the contribution of bacterial compo-
nents to the induction of the host inflammatory re-
sponse once bacteria gain access to the cerebro-
spinal fluid (CSF). An understanding of which
bacterial component(s) incites the host response is
important since products of inflammation that are
released during infection may injure host tissues
and be detrimental to the recovery from disease
[1-3]. This information may provide important
clues as to why mortality from pneumococcal dis-
ease remains at 20070 despite the development of
new, highly bactericidal antibiotics [4]. We present
evidence that of the major surface components, the
cell wall, and not capsular polysaccharide, appears
to be a powerful inducer of the meningeal inflam-
matory response.
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Materials and Methods
Bacterial strains. Streptococcus pneumoniae
strain All is an encapsulated Rockefeller University
laboratory strain (Type II). Strains R6 and lyt 4-4
(an autolysin-deficient tolerant strain) are unencap-
sulated and derived from strain All [5]. Strain SIll
is a clinical isolate (Type III) obtained from Dr. M.
Sande (San Francisco General Hospital Medical
Center, San Francisco, Cali!). Strain 8249(TypeXIX)
is a penicillin-tolerant and penicillin-resistant clini-
cal isolate obtained from Dr. Koornhof (Johannes-
burg, South Africa).
Preparationofinocula. Bacteria weregrown for
6-8 hr in a synthetic medium [6] supplemented with
0.1% yeast extract (Difco, Detroit, Mich) to mid-
logarithmic phase. The cellswerecentrifuged at 2,000
g for 10min at 4 C, then washed, resuspended, and
diluted in pyrogen-free saline (elBA-GEIGY, Basel,
Switzerland), and injected into the cisterna magna.
Inoculum was titrated for cfu on trypticase soy broth
(TSB) agar plates containing 5% sheep blood.
Meningitis model. Male chinchilla rabbits weigh-
ing 2 kg (Thorn Farm, Biebarach an der Riss, Fed-
eral Republic of Germany) were prepared according
to the method of Dacey and Sande [7]. Unless other-
wise noted, four rabbits were tested for each varia-
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ble examined. Under anesthesia with 30 mg/kg iv
pentobarbital (Abbot AG, Zug, Switzerland), a den-
tal acrylic helmet was attached to the crown of the
calvarium. A minimum of 24 hr later, the rabbits
were again anesthetized with 1.75g/kg sc ethyl car-
bamate (Urethan'"; Fluka, Buchs, Switzerland) and
15mg/kg iv pentobarbital and positioned in a stero-
taxic frame. A spinal needle measuring 25 gauge by
3.5 inch (Becton-Dickinson, St. Augustine de Quad-
alix, Spain) was introduced into the cisterna magna
and fixed in position on the frame; 0.3 ml of CSF
was withdrawn and 0.2 ml of bacteria or bacterial
component in pyrogen-free diluent was introduced.
Serial 0.3-ml samples of CSF were obtained over the
subsequent 12-hrof anesthesia. For sampling beyond
this time, the rabbits were reanesthetized with pen-
tobarbital (as above) as required.
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Immediately upon withdrawal, CSF samples were
analyzed for number of cfu as above. Red and white
blood cell counts were determined in a Sysmex
Microcell Counter (CC-I08; TDA, Kobe, Japan).
When red blood cells were detected, the number of
leukocytes was adjusted to correct for contamina-
tion of CSF by blood. The remainder of each CSF
sample was centrifuged (10,000 g, 3 min) with an Ep-
pendorff microcentrifuge, and the supernatant was
frozen and stored at -70 C for subsequent chemi-
cal analysis. Glucose was determined by a micro-
adaptation of a commercial assay kit (Test-com-
bination glucose; Boehringer Mannheim, GmbH,
Federal Republic of Germany), protein by the Lowry
method [8], and lactic acid by a microadaptation of
a commercial assay kit (Sigma UV test 826-UV;
Sigma Chemical, St. Louis, Mo.).
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Figure 1. Growth rate of five strains of S. pneumoniae inoculated intracisternally into rabbits. Bacteria were prepared
as outlined in Materials and Methods, and the inoculum was adjusted to rv 104 cfu/ml. For each strain, 0.2 ml of
this suspension was introduced into the cisterna magna of each of four rabbits. The numbers of cfu/ml in CSF were
then observed over time. Strain R6 (e); strain 8249 (x); strain SIll (0); strain lyt 4-4 (_); and strain An (.6.). Each
data point is the mean ± standard error of the mean (SEM) of four rabbits. t = all animals in the group died; and
s = all animals in the group survived. LDso for each strain is as follows: R6 = 107 ; An = 106 ; SIll = 102 ; and 8249
= 102 •
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Preparation of killed bacteria and bacterial com-
ponents. S. pneumoniae strain Au, SUh or R6 was
grown until the bacterial concentration reached 108
cfu/ml (verified by cfu titration). A 10-ml culture
was placed in a boiling water bath for 10 min and
then centrifuged at 2,000 g for 10 min, washed and
resuspended in pyrogen-free saline. The recovery of
bacterial cells (i.e., cell-sized particles) was deter-
mined by a Coulter Counter Model T All (Coulter
Electronics, Harpenden, Hertfordshire, England).
Pneumococcal capsular polysaccharide was pre-
pared by dissolving the 14-component pneumococ-
cal polysaccharide vaccine (Pneumovax"; Merck,
Sharp & Dohme, Rahway, NJ) in pyrogen-free sa-
line, and the solution (5 mg of polysaccharide/rnl)
was dialyzed extensively against pyrogen-free saline
in the cold. (Dialysis membrane was prepared by boil-
ing, soaking in 0.5 M EDTA, and then rinsing in
pyrogen-free saline.) Purified pneumococcal cell
walls were prepared as described previously [5]. The
cell wall preparations were weighed and resuspended
in pyrogen-free saline at a concentration of 1 mg/rnl.
The suspensions were homogenized by a brief (2-3
sec) exposure to sonication (Branson Sonifier, model
W 225 R; Heat Systems Ultrasonics, Farmingdale,
NY) before inoculation into rabbits.
Statistics. Statistical differences between the
mean values for two groups of rabbits were calcu-
lated by using the two-tailed t test.
Results
Growth oj encapsulated and unencapsulated
pneumococci in vivo. All pneumonococcal strains
tested had the capacity to grow in CSF (figure 1).
Encapsulated strains did not have shorter generation
times. The lag time before the onset of growth and
the growth rates were characteristic of each strain
and did not correlate with the presence of bacterial
capsule. Lethal meningitis could be induced despite
lack ofcapsular polysaccharide when inocula of high
bacterial titer (107 cfu/ml) were used. The presence
of capsule was associated with higher and more sus-
tained bacterial density in CSF.
Variation in CSF chemistry in response to encap-
sulated and unencapsulated pneumococci. The
time course and magnitude of the cellular and chem-
ical changes in CSF following inoculation with two
encapsulated strains (Types III and XIX), unencap-
sulated (R6 ) pneumococci, and pyrogen-free saline
are shown in figure 2. These data were obtained in
parallel with the growth curves of figure 1 and can
be compared directly. Saline alone did not induce
abnormal changes.in CSF cytochemistry. Leukocytes
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Figure 2. CSF cytochemical profile following intracisternal inoculation of three strains of S. pneumoniae into rabbits.
Samples were collected in parallel with those described in figure 1. Each data point represents the mean (± SEM)
of samples from four rabbits. Strain R6 (e); strain 8249 (x); strain SIll (0); and saline (A.).
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Figure 3. Changes in CSF cytochemical profile induced by various concentrations of killed pneumococci, purified
cell wall, or capsular polysaccharide. Inocula of 2 x 107 heat-killed R6 per 0.2 ml (.) or 2 X 107 heat-killed Sm
per 0.2 ml (0) were each introduced into the cisterna magna of four rabbits. Inoculation of 0.2 ml of saline produced
results identical to killed SIll (P> .5). Purified cell wall and capsular polysaccharide were each instilled into the cisterna
magna of four rabbits at c.oncentrations present on 106 cells (cell wall ~, capsule 0), or alternatively at 2 mg/0.2
ml (cell wall 1ITl, capsule 0). CSF was withdrawn at 5 and 24 hr postinoculation and analyzed as indicated (mean
± SEM).
appeared in CSF at different times postinoculation;
the striking finding was the correlation of the onset
of the influx of leukocytes with the time when the
bacterial density surpassed 105 organisms/ml. After
the appearance of leukocytes, the CSF protein and
lactic acid concentration began to increase. Both the
sequence and magnitude of these changes weresimi-
lar regardless of the presence or absence of capsule
on the bacterium. Glucose concentration decreased
only when organisms grew to a density >106 cfu/ml.
Glucose concentrations decreased to <50 mg/dl dur-
ing the inflammatory response to 108 unencapsulated
organisms.
Difference in the CSF response induced by killed
pneumococci. The lack of correlation between in-
duction of the CSF inflammatory response and the
presence of bacterial capsule suggested that bacterial
components other than the capsule may be impor-
tant in provoking the host response. The fact that
all strains invoked a response at a similar bacterial
density in CSF (i.e., 105) indicated that the inciting
component had to be present in critical amounts to
provoke a response. These two observations sug-
gested that killed bacteria without capsule might also
induce a CSF inflammatory response if given in the
appropriate dose. Indeed, heat-killed preparations
of unencapsulated bacteria when administered at
~105 cell equivalents per dose produced a CSF re-
sponse remarkably similar to that of live bacteria
(figure 3). Lower concentrations of killed organisms
produced little inflammatory response in the CSF.
In contrast to heat-killed unencapsulated bacte-
ria, heat-killed encapsulated inocula (106 and 108
cells) evoked only a minimal inflammatory response
(P < .01, figure 3). This lack of activity did not ap-
pear to be due to alteration of the capsule by heat-
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ing since heated-isolated capsular polysaccharide
retained reactivity equal to that of untreated prepa-
rations (data not shown).
One striking difference in the CSF biochemical
profile was noted when comparing live and killed
inocula. CSF glucose concentrations remained nor-
mal during the response initiated by a killed inocu-
lum (figure 3). On the other hand, both protein and
lactic acid concentrations increased after the inocu-
lation of live or killed unencapsulated bacteria. In-
oculation of >108 killed bacterial cells failed to in-
duce hypoglycorrhachia.
Comparison oj isolated cell wall and capsular
polysaccharide as inducers ojCSF inflammatory re-
sponse. Inoculation of >105killed cells evoked an
inflammatory response: this corresponds to t"V0.02
Jigof cell wall material. Cell equivalents of capsular
polysaccharide are difficult to calculate since the ma-
terial is constantly shed into the medium during bac-
terial growth. However, 0.2 Jig approximates the
amount on 105 cells [9]. Figure 3 details the inflam-
matory response produced by inoculation of 106cell
equivalents of cell wall or capsular polysaccharide.
Capsular polysaccharide produced little response at
this concentration (mild increase in 24-hr CSF pro-
tein concentration). Cell wall material, on the other
hand, evoked an inflammatory response similar to
that of whole cells, including pleocytosis and an in-
crease in protein and lactic acid concentrations; glu-
cose concentration remained normal.
The inflammatory response generated by inocula
of 2 mg of these two components is depicted in fig-
ure 3 (t"Vl08 cell equivalents of cell wall and t"Vl09 cell
equivalents of capsular polysaccharide). At these
concentrations both preparations induce inflamma-
tion although the magnitude of the response to cell
wall is significantly greater than that to capsule.
Discussion
The CSF inflammatory response to all strains of
pneumococci tested was similar, consisting of leu-
kocytosis, an increase in protein and lactic acid con-
centrations, and hypoglycorrhachia. The fact that
pneumococci with widely varying surface character-
istics (differing capsular types or absence of capsule)
could produce qualitatively and quantitatively simi-
lar CSF responses suggests that bacterial compo-
nents other than capsule, yet common to all strains,
are critical to the induction of CSF inflammatory
changes. Potent inflammatory activity was found to
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reside in the cell wall of pneumococci. Most impor-
tantly, purified wall was active in inducing CSF in-
flammation at a concentration of t"Vl06 whole-cell
equivalents. This number corresponds closely to the
threshold at which CSF inflammation was found to
begin with living bacteria (compare figures 1and 2).
In contrast, capsular polysaccharide was inactive at
2 Jig per dose, an amount that represents not only
t"VI06whole-cell equivalents but is also 10-100-fold
greater than the concentration of capsule detected
in rabbit CSF in meningitis [9].
Our experiments do not unequivocally identify the
pneumococcal cell walls as the sole agents responsi-
ble for the inflammation observed in pneumococ-
cal meningitis. A variety of bacterial components
(intramembrane or intracellular) can induce inflam-
mation in the CSF (authors' unpublished observa-
tions). Nevertheless, the pneumococcal cell wall is
a plausible candidate for such a role, and our ex-
periments clearly show that the specific activity of
cell wall material as an inducer of inflammation is
high enough to be operative at the bacterial concen-
trations observed in pneumococcal meningitis.
The mechanism whereby cell walls induce CSF in-
flammation is an yet unclear. The inflammatory ac-
tivity of the cell wall has been noted in other ex-
perimental systems [10-14]. The pneumococcal cell
wall is known to activate the alternative pathway of
complement [15, 16] and could in this manner poten-
tially generate chemotaxins and damage to the
blood-brain barrier early in the course of infection.
It should be noted, however,that CSF contains very
little complement even during the later stages of
meningitis [17, 18].Chemotactic activity in CSF has
been noted to be associated with heat stable sub-
stances of low molecular weight, some of which are
generated during bacterial growth [19]. It is conceiv-
able that cell wall components may be directly
responsible for some of this chemotactic activity.
Killedencapsulated strains wereinactive, a result sug-
gesting the presence of capsular material may mask
the inflammatory activity ofthe underlying cellwall.
It is conceivable that encapsulated bacteria produce
inflammation by exposure of the underlying cellwall
or by secretion of the cell wall material during
growth.
Only actively multiplying organisms at ~106
cfu/ml were found to induce hypoglycorrhachia.
These results are similar to those obtained in vitro
by Petersdorf et al. [20-22]. The mechanism of CSF
hypoglycorrhachia in meningitis is unclear. The dis-
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sociability of glucose and lactic acid changes would
suggest that increases in the level of lactic acid can-
not be taken as evidence of anaerobic glycolysis of
decreasing CSF glucose. Our data suggest that the
decrease in the level of glucose in CSF is caused by
bacterial metabolic products other than the cellwall.
The potential clinical relevance of the CSF re-
sponse to cell wall material rests on the correlation
between the clinical outcome of meningitis and the
degree of inflammation [23]. Pneumococcal cell wall
components are released into the surrounding
medium during stationary-phase autolysis and, per-
haps more importantly, during treatment of pneu-
mococci with fJ-Iactam antibiotics. Thus, it is con-
ceivable that bacterial death, when accompanied by
lysis and release of cell wall, could aggravate CSF
inflammation and affect the clinical outcome of dis-
ease deleteriously. This concept may explain in part
the occurrence of deaths despite bacteriologic cure
of the patient.
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